Accueil   Diary - News   All news ImmunID at ASCO Annual Meeting

ImmunID at ASCO Annual Meeting

ImmunID, the immune companion diagnostics for precision medicine company, today announces that a collaborative work on prediction of response to the antiPD1 and anti-CTLA-4 immune checkpoint inhibitors in melanoma using ImmunTraCkeR® has been selected for a poster presentation during the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, IL on June 3-7, 2016. These results were generated in collaboration with Zurich University Hospital (Switzerland) and the NKI (The Netherlands), two leading European clinical centers in Immuno-Oncology.


Read the press release

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree